High concentrations of commonly used drugs can inhibit the in vitro glucuronidation of bisphenol A and nonylphenol in rats

Xenobiotica

Volumn 40, Issue 2, 2010, Pages 83-92

  Verner, M A ^a   Magher, T ^a   Haddad, S ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Bisphenol A; Drugs; Hepatocytes; Interactions; Metabolism; Microsomes; P nonylphenol; Rat

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AMOXICILLIN; CARBAMAZEPINE; CIMETIDINE; DICLOFENAC; ERYTHROMYCIN; GLICLAZIDE; IBUPROFEN; MEFENAMIC ACID; NAPROXEN; NONYLPHENOL; PARACETAMOL; RANITIDINE; SALAZOSULFAPYRIDINE; SALICYLIC ACID; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GLUCURONIDATION; IN VITRO STUDY; LIVER CELL; LIVER MICROSOME; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBAMAZEPINE; CELLS, CULTURED; DRUG INTERACTIONS; ENDOCRINE DISRUPTORS; GLUCURONIDES; HEPATOCYTES; MALE; METABOLIC DETOXICATION, DRUG; MICROSOMES, LIVER; NAPROXEN; PHARMACEUTICAL PREPARATIONS; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; SALICYLIC ACID;

RATTUS;

EID: 75649110847     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498250903383334     Document Type: Article

References (45)

1. Allgayer H, Kruis W, Eisenburg J, Paumgartner G. (1984). Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis. Eur J Clin Pharmacol 26(2):275-277
2. Bechi N, Ietta F, Romagnoli R, Focardi S, Corsi I, Buffi C, Paulesu L. (2006). Estrogen-like response to p-nonylphenol in human first trimester placenta and BeWo choriocarcinoma cells. Toxicol Sci 93(1):75-81.
3. Bodey GP, Nance J. (1972). Amoxicillin: in vitro and pharmacological studies. Antimicrob Agents Chemother 1(4):358-362
4. Brantmark B, Wahlin-Boll E, Melander A. (1982). Bioavailability of acetylsalicylic acid and salicylic acid from rapid- and slow-release formulations, and in combination with dipyridamol. Eur J Clin Pharmacol 22(4):309-314
5. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. (1995). Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103(6):608-612
6. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. (2005). Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113(4):391-395
7. Daidoji T, Inoue H, Kato S, Yokota H. (2003). Glucuronidation and excretion of nonylphenol in perfused rat liver. Drug Metab Dispos 31(8):993-998
8. Davis TM, Daly F, Walsh JP, Ilett KF, Beilby JP, Dusci LJ, Barrett PH. (2000). Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes. Br J Clin Pharmacol 49(3):223-230
9. De Brabander C, Vervaet C, Gortz JP, Remon JP, Berlo JA. (2000). Bioavailability of ibuprofen from matrix mini-tablets based on a mixture of starch and microcrystalline wax. Int J Pharm 208(1-2):81-86
10. Elsby R, Maggs JL, Ashby J, Park BK. (2001). Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J Pharmacol Exp Ther 297(1):103-113
11. Ethell BT, Anderson GD, Burchell B. (2003). The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP- glucuronosyltransferases. Biochem Pharmacol 65(9): 1441-1449
12. Grahnen A, von Bahr C, Lindstrom B, Rosen A. (1979). Bioavailability and pharmacokinetics of cimetidine. Eur J Clin Pharmacol 16(5):335-340
13. Guenther K, Heinke V, Thiele B, Kleist E, Prast H, Raecker T. (2002). Endocrine disrupting nonylphenols are ubiquitous in food. Environ Sci Technol 36(8):1676-1680
14. Haddad S, Blanchette E, Rheault I, Verner M-A. (2009). Pharmacokinetic interactions between bisphenol A and naproxen in humans. The Toxicologist CD-Official Journal of the Society of Toxicology 108(S-1):204, abst 285.
15. Hanioka N, Naito T, Narimatsu S. (2008). Human UDPglucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Chemosphere 74(1):33-36
16. Hjelle JJ, Hazelton GA, Klaassen CD. (1985). Acetaminophen decreases adenosine 3″-phosphate 5″-phosphosulfate and uridine diphosphoglucuronic acid in rat liver. Drug Metab Dispos 13(1):35-41.
17. Howell SR, Hazelton GA, Klaassen CD. (1986). Depletion of hepatic UDP-glucuronic acid by drugs that are glucuronidated. J Pharmacol Exp Ther 236(3):610-614
18. Hussein Z, Mukherjee D, Lamm J, Cavanaugh JH, Granneman GR. (1994). Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation. J Clin Pharmacol 34(7):754-759
19. Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. (2002). Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 17(11):2839-2841
20. Inoue H, Yuki G, Yokota H, Kato S. (2003). Bisphenol A glucuronidation and absorption in rat intestine. Drug Metab Dispos 31(1):140-144
21. Inoue K, Kondo S, Yoshie Y, Kato K, Yoshimura Y, Horie M, Nakazawa H. (2001). Migration of 4-nonylphenol from polyvinyl chloride food packaging films into food simulants and foods. Food Addit Contam 18(2):157-164
22. Kawaguchi M, Inoue K, Sakui N, Ito R, Izumi S, Makino T, Okanouchi N, Nakazawa H. (2004). Stir bar sorptive extraction and thermal desorption-gas chromatography-mass spectrometry for the measurement of 4-nonylphenol and 4-tert-octylphenol in human biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 799(1):119-125 (Pubitemid 37500870)
23. Kiang TK, Ensom MH, Chang TK. (2005). UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 106(1):97-132.
24. King C, Tang W, Ngui J, Tephly T, Braun M. (2001). Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicol Sci 61(1):49-53.
25. Kirchheiner J, Meineke I, Steinbach N, Meisel C, Roots I, Brockmoller J. (2003). Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans. Br J Clin Pharmacol 55(1):51-61.
26. Kuch HM, Ballschmiter K. (2001). Determination of endocrine-disrupting phenolic compounds and estrogens in surface and drinking water by HRGC-(NCI)-MS in the picogram per liter range. Environ Sci Technol 35(15):3201-3206
27. Kuester RK, Sipes IG. (2007). Prediction of metabolic clearance of bisphenol A (4,4″-dihydroxy-2,2-diphenylpropane) using cryopreserved human hepatocytes. Drug Metab Dispos 35(10):1910-1915
28. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. (2000). Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 54(1):154-167
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265-275
30. Mano Y, Usui T, Kamimura H. (2007). Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDPglucuronosyltransferase 2B7 in human liver microsomes. Eur J Clin Pharmacol 63(2):211-216
31. Matthews JB, Twomey K, Zacharewski TR. (2001). In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem Res Toxicol 14(2):149-157
32. Miller R, Ludden TM. (1993). Bioavailability of controlled release carbamazepine estimated by mixed effect modelling. Eur J Clin Pharmacol 44(3):231-235
33. Moffat GJ, Burns A, Van Miller J, Joiner R, Ashby J. (2001). Glucuronidation of nonylphenol and octylphenol eliminates their ability to activate transcription via the estrogen receptor. Regul Toxicol Pharmacol 34(2):182-187
34. Morichau-Beauchant M, Houin G, Mavier P, Alexandre C, Dhumeaux D. (1986). Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients. Dig Dis Sci 31(2):113-118
35. Mroszczak E, Yee JP, Bynum L. (1988). Absorption of naproxen controlled-release tablets in fasting and postprandial volunteers. J Clin Pharmacol 28(12):1128-1131
36. Neuvonen PJ, Kivisto KT. (1988). Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. Eur J Clin Pharmacol 35(5):495-501.
37. Otaka H, Yasuhara A, Morita M. (2003). Determination of bisphenol A and 4-nonylphenol in human milk using alkaline digestion and cleanup by solid-phase extraction. Anal Sci 19(12):1663-1666
38. Patel DK, Notarianni LJ, Bennett PN. (1990). Comparative metabolism of high doses of aspirin in man and rat. Xenobiotica 20(8):847-854
39. Pritchard M, Fournel-Gigleux S, Siest G, Mackenzie P, Magdalou J. (1994). A recombinant phenobarbital-inducible rat liver UDPglucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Mol Pharmacol 45(1):42-50.
40. Rawlins MD, Henderson DB, Hijab AR. (1977). Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol 11(4):283-286
41. Teeguarden JG, Waechter JM, Jr., Clewell HJ, 3rd, Covington TR, Barton HA. (2005). Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol Sci 85(2):823-838
42. Thompson PJ, Burgess KR, Marlin GE. (1980). Influence of food on absorption of erythromycin ethyl succinate. Antimicrob Agents Chemother 18(5):829-831
43. Uchaipichat V, Mackenzie PI, Guo XH, Gardner-Stephen D, Galetin A, Houston JB, Miners JO. (2004). Human UDPglucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos 32(4):413-423
44. Vivacqua A, Recchia AG, Fasanella G, Gabriele S, Carpino A, Rago V, Di Gioia ML, Leggio A, Bonofiglio D, Liguori A , Maggiolini M. (2003). The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells. Endocrine 22(3):275-284
45. Yokota H, Iwano H, Endo M, Kobayashi T, Inoue H, Ikushiro S, Yuasa A. (1999). Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDPglucuronosyltransferase, UGT2B1, in the rat liver. Biochem J 340(Pt 2):405-409